$AMGN Triggered Lows NASDAQ:AMGN has alerted for a potential move lower. Target is set for 313.49. Will need some volume or wind from the market for this move.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.85USD
6.72 BUSD
28.01 BUSD
536.05 M
About Amgen Inc.
Sector
Industry
CEO
Robert A. Bradway
Website
Headquarters
Thousand Oaks
Founded
1980
FIGI
BBG000BBS2Y0
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Amgen: False Breakdown and Uptrend?Amgen has been fighting higher this year, and some traders may think a longer-term uptrend is in place.
The first pattern on today’s chart is the move under $310 after mixed quarterly results. The drugmaker quickly recovered as Wall Street focused on its pipeline. The resulting drop and rebound cou
Long OP Motivation
Bear candle is rejected.
Company outlook is bullish.
Price/earning spiral looks to establish.
AMGN - Increased Probability of AppreciationAMGN has the support of Fiboclouds indicating an increased probability of appreciation at least until the first target. The second target should be tested, provided the stop loss is properly repositioned at the time of the first partial realization.
If this projection is confirmed and a partial rea
AMGN breaking above supply and fib levelThis good be a good risk vs reward. This stock has been acting nice breaking above recent highs and fib level. Also its sector seems to be for now breaking out.
Buyback Patterns for Swing TradingNASDAQ:AMGN shows a buyback run followed by a sell day that was instigated by market makers as buyers quickly disappeared. Remember that corporate buybacks are done by bank floor traders to add stock to their inventory so they won't take profits at the peak of the run; those are other market partic
AMGN Puts 290 Strike August 16th Expiration.I believe "AMGN" will get to around 217.7ish and then dip. From a technical viewpoint I believe its showing a "head and shoulders top" based on a chart that looks back since August of 2023. I am a rookie and don't know if this is true but am basing it on that. From a fundamental viewpoint I believe
Amgen's MariTide Shakes Up Weight Loss Drug MarketThe weight loss drug market, projected to hit $100 billion by the decade's end, is undergoing significant innovation. Amidst dominant players like Novo Nordisk and Eli Lilly, Amgen is emerging with MariTide, a potentially game-changing drug set to disrupt the industry. MariTide's extended-release fo
AMGN Rises as CEO Celebrates Growth in Experimental Obesity DrugAmgen Inc.'s shares ( NASDAQ:AMGN ) rose by 15.9% when the market opened on Friday, marking its biggest intraday rise since July 2009. The company has emerged as a potential competitor to Eli Lilly & Co. and Novo Nordisk A/S, which currently dominate the weight-loss market. Demand for anti-obesity d
AMGN potential buy setupReasons for bullish bias:
- Price bounced from support
- Weekly bullish candle closing at support
- 0.5 fib retracement
Entry Level (CMP): 278.40
Stop Loss Level: 264.03
Take Profit Level 1: 292.77
Take Profit Level 2: 307.14
Take Profit Level 3: Open
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where AMGN is featured.
Frequently Asked Questions
The current price of AMGN is 320.16 USD — it has increased by 0.88% in the past 24 hours. Watch Amgen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Amgen Inc. stocks are traded under the ticker AMGN.
AMGN stock has risen by 1.24% compared to the previous week, the month change is a −1.16% fall, over the last year Amgen Inc. has showed a 24.93% increase.
We've gathered analysts' opinions on Amgen Inc. future price: according to them, AMGN price has a max estimate of 405.00 USD and a min estimate of 200.00 USD. Watch AMGN chart and read a more detailed Amgen Inc. stock forecast: see what analysts think of Amgen Inc. and suggest that you do with its stocks.
AMGN reached its all-time high on Jul 25, 2024 with the price of 346.85 USD, and its all-time low was 0.08 USD and was reached on Nov 19, 1984. View more price dynamics on AMGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AMGN stock is 2.49% volatile and has beta coefficient of 0.41. Track Amgen Inc. stock price on the chart and check out the list of the most volatile stocks — is Amgen Inc. there?
Today Amgen Inc. has the market capitalization of 169.55 B, it has decreased by −0.05% over the last week.
Yes, you can track Amgen Inc. financials in yearly and quarterly reports right on TradingView.
Amgen Inc. is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
AMGN earnings for the last quarter are 5.58 USD per share, whereas the estimation was 5.17 USD resulting in a 7.88% surprise. The estimated earnings for the next quarter are 5.12 USD per share. See more details about Amgen Inc. earnings.
Amgen Inc. revenue for the last quarter amounts to 8.50 B USD, despite the estimated figure of 8.51 B USD. In the next quarter, revenue is expected to reach 8.86 B USD.
AMGN net income for the last quarter is 746.00 M USD, while the quarter before that showed −113.00 M USD of net income which accounts for 760.18% change. Track more Amgen Inc. financial stats to get the full picture.
Yes, AMGN dividends are paid quarterly. The last dividend per share was 2.25 USD. As of today, Dividend Yield (TTM)% is 2.81%. Tracking Amgen Inc. dividends might help you take more informed decisions.
Amgen Inc. dividend yield was 2.96% in 2023, and payout ratio reached 68.24%. The year before the numbers were 2.95% and 64.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 1, 2024, the company has 26.70 K employees. See our rating of the largest employees — is Amgen Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amgen Inc. EBITDA is 11.57 B USD, and current EBITDA margin is 44.11%. See more stats in Amgen Inc. financial statements.
Like other stocks, AMGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amgen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amgen Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amgen Inc. stock shows the buy signal. See more of Amgen Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.